4.6 Article

The solution structure of the kallikrein-related peptidases inhibitor SPINK6

Journal

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2016.01.172

Keywords

SPINK6; Kallikrein-related peptidase 4; KLK4; Structure; Model protease - inhibitor complex; Nuclear magnetic resonance

Funding

  1. Deutsche Forschungsgemeinschaft [SFB 877, ME2037/3-3]
  2. Dutch Foundation for Scientific Research (NWO) [722.014.005]
  3. Austrian Science Fund FWF [P25003-B21]
  4. Excellence Cluster 306 'Inflammation at Interfaces'
  5. Austrian Science Fund (FWF) [P 25003] Funding Source: researchfish
  6. Austrian Science Fund (FWF) [P25003] Funding Source: Austrian Science Fund (FWF)

Ask authors/readers for more resources

Kallikrein-related peptidases (KLKs) are crucial for epidermal barrier function and are involved in the proteolytic regulation of the desquamation process. Elevated KLK levels were reported in atopic dermatitis. In skin, the proteolytic activity of KLKs is regulated by specific inhibitors of the serine protease inhibitor of Kazal-type (SPINK) family. SPINK6 was shown to be expressed in human stratum corneum and is able to inhibit several KLKs such as KLK4, -5, -12, -13 and -14. In order to understand the structural traits of the specific inhibition we solved the structure of SPINK6 in solution by NMR-spectroscopy and studied its interaction with KLKs. Thereby, beside the conserved binding mode, we identified an alternate binding mode which has so far not been observed for SPINK inhibitors. (C) 2016 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available